Related references
Note: Only part of the references are listed.Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Mikko Taipale et al.
CELL (2012)
Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
Joseph M. Gozgit et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Arvin C. Dar et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
Matthew P. Patricelli et al.
CHEMISTRY & BIOLOGY (2011)
Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site
Jingsong Yang et al.
CHEMISTRY & BIOLOGY (2011)
Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
Johanna M. Kralik et al.
DIAGNOSTIC PATHOLOGY (2011)
Trends in Kinase Selectivity Insights for Target Class-Focused Library Screening
Shana L. Posy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies
Joseph M. Gozgit et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
Roxana E. Iacob et al.
PLOS ONE (2011)
Infantile Fibrosarcoma: Management Based on the European Experience
Daniel Orbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang et al.
NATURE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Thomas O'Hare et al.
CANCER CELL (2009)
The interplay of structural information and functional studies in kinase drug design: insights from BCR-Abl
Michael J. Eck et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell
Yunchen Gong et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
A simple, flexible and efficient PCR-fusion/Gateway cloning procedure for gene fusion, site-directed mutagenesis, short sequence insertion and domain deletions and swaps
Ivan I. Atanassov et al.
PLANT METHODS (2009)
Calorimetry and thermodynamics in drug design
Jonathan B. Chaires
ANNUAL REVIEW OF BIOPHYSICS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
High-throughput kinase profiling as a platform for drug discovery
David M. Goldstein et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
Oleg Fedorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
Helen Y. Zou et al.
CANCER RESEARCH (2007)
TICdb:: a collection of gene-mapped translocation breakpoints in cancer
Francisco J. Novo et al.
BMC GENOMICS (2007)
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Anna V. Galkin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structure of an Hsp90-Cdc37-Cdk4 complex
Cara K. Vaughan et al.
MOLECULAR CELL (2006)
Chaperoning steroid hormone action
Didier Picard
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli
MJ Kerner et al.
CELL (2005)
ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages
CL Lannon et al.
SEMINARS IN CANCER BIOLOGY (2005)
High-throughput mapping of a dynamic signaling network in mammalian cells
M Barrios-Rodiles et al.
SCIENCE (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex
WP Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
Stabilization of proteins by ligand binding: Application to drug screening and determination of unfolding energetics
TT Waldron et al.
BIOCHEMISTRY (2003)
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
M Azam et al.
CELL (2003)
Novel retroviral vectors to facilitate expression screens in mammalian cells
EY Koh et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
